Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioSpring
Frankfurt am Main, Hessen, Germanybiospring.de ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
BioSpring is a global leader in nucleic acid manufacturing and analytics, providing high-quality solutions for therapeutic nucleic acids across all clinical phases and commercial production[1][2].
- Therapeutic areas
- OncologyRare DiseasesInfectious Diseases
- Modalities
- Nucleic acidsoligonucleotidesantisense oligonucleotides (ASOs)guide RNA (gRNA)messenger RNA (mRNA)small interfering RNA (siRNA)DNA fragments
- Industry
- Contract Manufacturing Organization
02
Partnerships
Pharmaceutical and biotech companies, academic institutions worldwide[2]
Beyond the preview
Go deeper on BioSpring.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioSpring.